US Patent 10538584 Methods for treating bone gap defects

Patent 10538584 was granted and assigned to Amgen on January, 2020 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

January 21, 2020

Patent Application Number

14233137

Date Filed

August 2, 2012

Patent Citations Received

Patent Primary Examiner

Patent abstract

The invention provides a method of enhancing bone gap defect healing involving administering a sclerostin inhibitor.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 10538584 Methods for treating bone gap defects

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

By using this site, you agree to our Terms of Service.